VERTEX PHARMACEUTICALS INC / MA Stockholders' Equity Attributable to Noncontrolling Interest
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2018-12-31, per its 10-K filed 2019-02-13.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2019-02-13
- 2018-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2018-09-30: Stockholders' Equity Attributable to Noncontrolling Interest $28.36M.
- 2018-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $28.66M.
- 2018-03-31: Stockholders' Equity Attributable to Noncontrolling Interest $29.77M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-13 |
| 2018-09-30 | $28.36M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $28.66M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $29.77M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $13.73M 10-K · filed 2019-02-13 |
| 2017-09-30 | $12.17M 10-Q · filed 2017-10-30 |
| 2017-06-30 | $195.96M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $182.78M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $181.61M 10-K · filed 2018-02-15 |
| 2016-09-30 | $186.79M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $187.49M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $159.12M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $153.66M 10-K · filed 2017-02-23 |
| 2015-09-30 | $154.59M 10-Q · filed 2015-10-30 |
| 2015-06-30 | $153.25M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $21.08M 10-Q · filed 2015-05-04 |
| 2014-12-31 | $21.18M 10-K · filed 2016-02-16 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |
| 2013-09-30 | $182.17M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $187.00M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $191.84M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $196.67M 10-K · filed 2014-02-11 |
| 2012-09-30 | $198.71M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $167.92M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $137.58M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $141.63M 10-K · filed 2013-03-01 |
| 2011-09-30 | $114.39M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $105.33M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |